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Background: Microglia/macrophages (MG/MΦ) are found in the subretinal space in both mice and humans. Our
goal was to study the spatial and temporal distribution, the phenotype, and gene expression of subretinal MG/MΦ
in mice with normal retinas and compare them to mice with known retinal pathology.
Methods: We studied C57BL/6 mice with (C57BL/6N), or without (C57BL/6J) the rd8 mutation in the Crb1 gene
(which, in the presence of yet unidentified permissive/modifying genes, leads to a retinal degeneration), and
documented their fundus appearance and the change with aging. Immunostaining of retinal pigment epithelium
(RPE) flat mounts was done for 1) Ionized calcium binding adaptor (Iba)-1, 2) FcγIII/II Receptor (CD16/CD32, abbreviated
as CD16), and 3) Macrophage mannose receptor (MMR). Reverse-transcription quantitative PCR (RT-qPCR) was done for
genes involved in oxidative stress, complement activation and inflammation.
Results: The number of yellow fundus spots correlated highly with subretinal Iba-1+ cells. The total number of
subretinal MG/MΦ increased with age in the rd8 mutant mice, but not in the wild-type (WT) mice. There was a
centripetal shift in the distribution of the subretinal MG/MΦ with age. Old rd8 mutant mice had a greater number
of CD16+ MG/MΦ. CD16+ cells had morphological signs of activation, and this was most prominent in old rd8
mutant mice (P <1×10−8 versus old WT mice). Subretinal MG/MΦ in rd8 mutant mice also expressed iNOS and
MHC-II, and had ultrastructural signs of activation. Finally, rd8 mutant mouse RPE/ MG/MΦ RNA isolates showed
an upregulation of Ccl2, CFB, C3, NF-kβ, CD200R and TNF-alpha. The retinas of rd8 mutant mice showed upregulation of
HO-1, C1q, C4, and Nrf-2.
Conclusions: When compared to C57BL/6J mice, C57BL/6N mice demonstrate increased accumulation of
subretinal MG/MΦ, displaying phenotypical, morphological, and gene-expression characteristics consistent with a
pro-inflammatory shift. These changes become more prominent with aging and are likely due to the combination of
the rd8 mutation and yet unidentified permissive/modulatory genes in the C57BL/6N mice. In contrast, aging leads to
a scavenging phenotype in the C57BL/6J subretinal microglia/macrophages.
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Microglia are the resident macrophages of the central ner-
vous system (CNS). The blood brain barrier and the blood
retina barrier do not allow the immune system an open
communication to the brain and retina respectively; this is
an important element of the immune privilege in the
CNS. Yet, these tissues have an extremely delicate homeo-
stasis that needs to be maintained. Microglia are the resi-
dent immune cells that constantly patrol/scavenge the
CNS, including the retina, to detect any pathologic state
(for example, damaged neurons, extracellular debris and
infectious agents) that would require a response.
Pathological activation of microglia may play an im-
portant causative role in Alzheimer’s disease and other
neurodegenerative diseases [1-3]. Since the retina is an
extension of the brain, it seems reasonable to predict
that activated microglia may also be at play in degenera-
tive retinal diseases. The relevance of microglia/macro-
phages (MG/MΦ) in age-related macular degeneration
(AMD) is supported by their presence in a very high per-
centage of both neovascular and geographic atrophy
specimens in human AMD cases [4-6]. In the Submacu-
lar Surgery Trial [7] about 80% of excised AMD-related
choroidal neovascular lesions contained macrophages.
More recently, microglia have been reported in the sub-
retinal space of patients with retinitis pigmentosa and
AMD [8]. Combadiere et al. found subretinal microglia
in patients with AMD, but not age-matched controls [9].
The cells were found in areas of localized retinal pig-
ment epithelium (RPE) disruption and/or photoreceptor
degeneration.
Subretinal MG/MΦ also appear to be important in
responding to retinal pathology in mice and other mam-
mals [9-14]. Accumulation of subretinal MG/MΦ has
been described in multiple models of acute and chronic
retinal pathology including increased light exposure [11],
blue light injury [15], laser-induced choroidal neovascular-
ization [16], and retinal degenerations [17,18]. Manipulat-
ing the receptors and ligands involved in microglial
migration (for example, CX3CR1, Ccr-2, and Ccl-2) can
also lead to an increased accumulation of subretinal
MG/MΦ [13,19,20]. Recently we described the generation
of complement factor H transgenic mice that develop
early signs of AMD, including the early accumulation of
basal laminar deposits [21]. Interestingly, these mice also
develop increased accumulation of subretinal MG/MΦ in
the central retina, despite the fact that we have not manip-
ulated any genes directly involved in the regulation of
macrophage trafficking and that they do not express the
recently described rd8 mutation. The rd8 mutation is a
single nucleotide deletion in the Crb1 gene that has been
found in many strains of mice, and leads to disruption of
the external limiting membrane of the retina [22,23]. In
the presence of yet undefined permissive/modulatorygenes, the rd8 mutation also results in a multifocal ret-
inal degeneration, and the accumulation of subretinal
MG/MΦ [22,24]. Luhmann et al. have recently identi-
fied a candidate region on chromosome 15 that may
carry one or more of these modifiers [25].
The role of subretinal MG/MΦ in maintaining homeo-
stasis and/or inducing disease is not well understood.
With this in mind, we decided to study the natural history
of subretinal MG/MΦ in C57BL/6 mice, either in the
presence (Group 1; referred to as Crb1rd8/rd8, or ‘rd8/rd8’,
or ‘rd8 mutant’, or C57BL/6N), or absence (Group 2; re-
ferred to as Crb1wt/wt, or ‘wt/wt’, or ‘WT’, or C57BL/6J) of
the Crb1 rd8 mutation. We first looked at the changes
with normal aging in the number, distribution, and pheno-
type/morphology of subretinal MG/MΦ in C57BL/6N
versus C57BL/6J mice. We also analyzed the expression of
complement activation and inflammation-related genes in




C57BL/6 (B6) mice of different ages that were either
homozygous (C57BL/6N from Charles River Labs), or
wild-type (WT) (C57BL/6J from The Jackson Lab and the
National Eye Institute (NEI) aging mouse colony) for the
rd8 mutation in the Crb1 gene were used for this study.
There was no difference in the number of fundus spots or
the number of ionized calcium binding adaptor (Iba)-1+
subretinal MG/MΦ for mice in the 2 to 4mo versus 5 to
8mo age ranges, or in the 14 to 16mo versus 17 to 20mo
age ranges, so mice were age-matched into two groups:
2- to 8-month-old (classified here as ‘young’) and 14- to
20-month-old (classified here as ‘old’). Specifically, for the
experiments involving immunohistochemistry (IHC) of
RPE-flat mounts we used: young mice (wt/wt or WT, n =
10; rd8/rd8, n = 8), and compared them to old mice (wt/
wt, n = 13; rd8/rd8, n = 11). For the qPCR experiments we
used 6- to 8-month-old C57BL6/J (wt/wt) mice from The
Jackson Lab (n = 11) and age-matched C57BL/6N (rd8/
rd8) mice from Charles River Labs (n = 11). Genotyping
for the rd8 mutation was done using the primers and
protocol previously described [23]. Sequencing for the rd8
mutation was done after a PCR reaction using the primers
and protocol described before [13]. All vendor animals
were acclimated to our animal facility for at least 1 month
before the experiments. The mice were kept in a barrier
animal facility at UT Southwestern Medical Center under
normal lighting conditions with 12 h-on/12 h-off cycles.
The average intensity inside the cages was 40 lux. Most
retina laboratories consider normal lighting conditions to
be 100 to 500 lux outside the cages [26,27], but less than
100 lux inside the cages [28,29]. All experiments were per-
formed in compliance with the National Institutes of
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Animals, and approved by the UT Southwestern Medical
Center Institutional Animal Care and Use Committee
(IACUC). Animals were anesthetized one at a time before
any procedures in order to prevent opacification of the
media. A ketamine-xylazine cocktail was used (100 mg/kg
ketamine, 5 mg/kg xylazine).
Fundus photography and fundus yellow spot counting
Eyes were dilated using one drop per eye of a tropicamide
1% solution (Alcon laboratories, Inc., Fort Worth, TX,
USA) 5 minutes before taking retinal images. A Micron
III rodent retinal imager (Phoenix Research Laboratories,
Pleasanton, CA, USA) was used to take bright field images
of the retinas. The yellow spots in either only the central
fundus (a circle with a radius equal to 5 disc diameters
and centered on the optic nerve), or in the entire fundus
(including all peripheral directions up to the ora serrata)
were counted. For the central counting, all images were
analyzed under identical parameters, and a transparent
plastic film marked with a circle having a 5 disc diameter
(DD) radius was placed over the fundus photographs and
centered on the optic nerve in order to standardize the
area to be counted.
Preparation of retinal pigment epithelium-choroid-sclera
flat mounts and immunohistochemistry
Eyes were enucleated, including the nictitating mem-
brane or ‘third eyelid’. This ‘third eyelid’ marked the
nasal aspect of the eye, allowing us to preserve the infor-
mation regarding orientation throughout the processing
of the eyes. The eye balls were placed in 4% paraformal-
dehyde for 2 hours at room temperature (RT). After two
washes in phosphate buffered saline (PBS), the removal
of the anterior segment was done in a modified way that
allowed us to preserve the entire posterior cup. We did
this by cutting the eye anterior to the limbus. The iris was
removed after confirming that we had preserved the pos-
terior segment all the way to the ora. The retina was then
removed from the RPE-choroid eyecup. The remaining
posterior eye cup (RPE-choroid-sclera complex, here re-
ferred to as ‘RPE flat mount’ or ‘flat mount) was flattened
by making 4 to 6 long radial cuts. The RPE flat mounts
were incubated in a blocking buffer of 5% bovine serum
albumin in 1X PBS (w/v) containing 0.3% (v/v) Triton X-
100 for 2 hours at RT. After removing the blocking buffer,
the flat mounts were incubated at 4°C overnight with pri-
mary antibodies prepared in a diluted (1:5) blocking buf-
fer. The flat mounts were single, double, or triple stained
for Iba-1, mouse Macrophage Mannose Receptor (MMR),
and/or mouse FcγIII/II Receptor (CD16/CD32, abbrevi-
ated as CD16). The antibodies and dilutions used were:
rabbit anti-Iba-1 (1:500), goat anti-MMR (1:50) and rat
anti-CD16 (1:25) (see Additional file 1: Table S1). Thenext day, flat mounts were washed 3 × 10 min in 1X PBS
and incubated with fluorophore-conjugated secondary
antibodies (1:200 dilution) for 2 h at room temperature.
The secondary antibodies for double staining experiments
included AF 594 donkey anti-rabbit, which was combined
with either AF488 donkey anti-goat or AF488 donkey
anti-rat. For triple staining experiments we used CF750
donkey anti-rabbit, AF 594 donkey anti-goat, and AF 488
donkey anti-rat. After three 10-min washes in 1X PBS, the
flat mounts were cover-slipped and mounted with Prolong
Gold antifade reagent with DAPI (double staining experi-
ments) or without DAPI (triple staining experiments).
Imaging and microglia/macrophage counting on retinal
pigment epithelium flat mounts
The flat mounts were photographed using a Zeiss AxioOb-
server motorized wide-field epifluorescence microscope
equipped with a Hamamatsu Orcall-BT-1024G mono-
chrome camera and fluorescence filter sets for FITC,
Texas Red, and CY7. Each flat mount was imaged using
Zeiss Axiovision software under two or three channels,
depending on the experiment, using the 10X objective
and 1.6x optivar. A set of images per location, that is, a
photographic field, in a flat mount were opened in Adobe
Photoshop and the cells were circled and counted for each
channel.
Measurement of microglial/macrophage morphology
activation parameters
Microglia/macrophages on flat mounts (n = 3 to 5 eyes
per group) that were triple stained for Iba-1, MMR and
CD16 were measured as follows: 3 to 5 snapshots/photo-
graphic field images from each flat mount were opened
in ImageJ software (http://imageJ.nih.gov/ij/index.html)
and 3 to 5 cells with intact body were randomly se-
lected by a masked investigator. The number of exten-
sions was counted. The area of the cell body and the
longest extension length were determined using Image
J. We combined these measurements into a new param-
eter that we named ‘microglial morphology activation
value’ (MMAV): MMAV = [cell body area]/[(largest ex-
tension length) × (# of extensions)].
Immunohistochemistry of retinal sections
Since the subretinal MG/MΦ are localized precisely where
artifactual retinal detachments occur during regular speci-
men preparation for retinal sections, we used a quick-
freezing of eyeballs followed by a freeze-substitution
technique. This method has been shown to be effective
in 1) preventing artifactual retinal detachment, 2) min-
imizing ice crystal formation, 3) preserving cellular
morphology, and 4) preserving antigenicity [30-34].
Eyes (n = 8 eyes per group) were enucleated and im-
mediately placed in 2-ml tubes with holes and frozen in
Aredo et al. Journal of Neuroinflammation  (2015) 12:6 Page 4 of 14liquid nitrogen-cooled isopentane for 2 minutes. The
tubes were immediately transferred to liquid nitrogen.
After all eyes were collected, the tubes with frozen eye
balls were transferred to a pre-cooled solution of metha-
nol/acetic acid (97:3; in -80°C freezer) in 50-ml tubes for
freeze substitution for at least 48 h. The eyes were grad-
ually warmed up to room temperature (first at -20°C for
24 h, then at 4°C for 4 h, and finally moved to RT). The
eyes were then transferred to 100% ethanol for paraffin
embedding using routine methods.
Sections were double stained with pairs of primary anti-
bodies (rabbit anti-Iba1 combined with either mouse anti-
iNOS, or anti-MHC class II-FITC, or rat anti-CD16/32),
followed by secondary antibodies (see Additional file 2:
Table S2). Primary antibodies were omitted in the control
sections. All samples were imaged on a Leica DMI300B
Microscope equipped with a Hamamatsu ORCA flash 4.0
camera, using Leica LAS AF software at 40X magnifica-
tion. The FITC channel (AF488) was used for iNOS,
MHC-II and CD16, while the Texas-Red channel (AF
594) was used for Iba-1.
Electron microscopy
After cardiac perfusion with 1% glutaraldehyde and 2%
paraformaldehyde in PBS (pH 7.4), fixed eyes were re-
moved and sectioned behind the limbus, and posterior
eyecups were processed as described before [21]. In
brief, eyes were post-fixed in osmium tetraoxide, dehy-
drated in ethanol series, and embedded in Poly/Bed 812
epoxy resin (Polysciences, Inc., Warrington, PA, USA).
For electron microscopy (EM), 70-nm thin sections were
cut, stained with 2% aqueous uranyl acetate and lead cit-
rate, and imaged using a JEOL 1200EX II transmission
electron microscope (JEOL USA, Inc) at the UT South-
western Medical Center EM Core Laboratory.
RNA extraction from retinal pigment epithelium and
retina of B6-WT and rd8 mutant mice
Eyes were enucleated and the anterior segment was re-
moved. The retina and the remaining posterior eye cup
(containing the RPE cells and overlying subretinal micro-
glia) were separated and processed differently. The retina
was placed in 500 μl Qiazol lysis reagent and was then ho-
mogenized using the Bio-Gen PRO200 Homogenizer (Pro
Scientific, Oxford, CT, USA). The Qiagen miRNeasy Mini-
Kit (Qiagen Sciences, LLC, Germantown, MD, USA; cat:
217004) was then used to isolate the total RNA. In the
meantime, the posterior eye cup was quickly dipped in
PBS in order to quickly wash out any adherent debris and
immediately transferred into a 1.5 ml microcentrifuge
tube containing 200 μl of RNAprotect cell reagent (Qia-
gen, cat. 76526). It took roughly 1 minute from the time
of enucleation to the transfer into the RNAprotect-
containing microcentrifuge tube. The posterior eye cupwas then processed using the SRIRS (simultaneous RPE
isolation and RNA stabilization) method that we described
[35] in order to isolate a high quality and quantity RNA
specifically derived from the RPE cells and overlying sub-
retinal MG/MΦ.
Quantitative RT-PCR
We used the Superscript III reverse transcriptase kit
(Invitrogen Inc., Grand Island, NY, USA; cat. 11735-032)
to generate cDNA from the extracted total RNA. Singlet
qPCR reactions were run in triplicate (iCycler; Bio-Rad
Laboratories, Hercules, CA, USA) at 95°C for 3 minutes,
followed by 40 cycles of 95°C for 15 seconds and 60°C
for 1 minute with SYBR Green ER qPCR SuperMix
(Invitrogen, cat. 11735-032). Each reaction contained 2.5
ng cDNA, 200 nM of each primer, and 10 μl qPCR super
mix in 20 μl total volume. The primers used are shown
in Additional file 3: Table S3 and Additional file 4: Table
S4. The fold changes in expression of the genes in the
RPE/microglia cell isolates were calculated using the for-
mula RQ = 2−ΔΔCt, and using GAPDH as an endogenous
reference gene.
Statistical analysis
SigmaPlot 11.0 (Systat Software Inc., San Jose, CA, USA;
http://www.sigmaplot.com) and/or Microsoft Excel was
used for statistical analysis. Data are presented as the
mean ± standard error of mean (SEM). A two-tailed Stu-
dent’s t-test was performed when comparing two groups
and a one-way analysis of variance (ANOVA) was ap-
plied to assess differences between groups, followed by
Tukey’s Test for all pairwise multiple comparison proce-
dures when necessary, and P value <0.05 was considered
significant.
Results
The distribution of yellow fundus spots on B6-mice
changes with age and rd8 mutation
Fundus examination of C57BL/6 mice revealed yellow
spots in mice of all ages (Figure 1). In young B6 mice
(2- to 8 mo) of both genotypes, the vast majority of the
spots were located in the far retinal periphery, close to the
ora serrata (Figure 1B and D). In this age group, a small
number of yellow spots were usually seen in the posterior
retina of C57BL6/N mice. However, these spots were seen
only rarely in the posterior retina of young C57BL/6J mice
(Figure 1A and C). As mice aged, the distribution of yel-
low spots shifted. In old mice (14-to 20 mo), the geo-
graphic distribution of these spots shifted towards the
mid-peripheral and central retina (Figure 1E,G, and black
bars in Figure 2C) in both genotypes. However, this
change was most accelerated in the C57BL/6N rd8 mutant
mice. The number of yellow spots in the central retina
was significantly higher in rd8 mutant compared to WT
Figure 1 Photographs of central and peripheral retina in
C57BL/6N (rd8/rd8) and C57BL/6 J (wild-type) mice. A change in
the distribution of fundus spots on B6-mice due to both age and the
presence of the rd8 mutation is seen. Yellow spots are shown in central
(A, C, E, and G) and peripheral (B, D, F, and H) fundus photographs
of representative young (A-D) and old (E-H) B6-mice. Mice 2 to 8
months of age were classified as ‘young’, while mice 14 to 20 months
of age were classified as ‘old’. Note that the number of central fundus
spots is increased in old age for both rd8 mutant (G versus C) and
wild-type (WT) (E versus A) mice. Furthermore, rd8/rd8 mice show a
marked increase in central spots compared to WT, both in the young
(C versus A) and old (G versus E) age groups.
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Figure 2C) for both age groups.
The microglia/macrophage cell count on retinal pigment
epithelium flat mounts corresponds to the number of
fundus yellow spots
Quantitative analysis was performed for the 1) yellow
spots in the central fundus (5 DD radius from the
nerve), 2) Iba-1+ cells on the RPE flat mounts within a
similar distance of the disc, and 3) Iba-1+ cells on the
entire RPE flat mounts. Figure 2A shows an entire flat
mount stained for Iba-1, and the area that was counted
as the central flat-mount (large white square). Fourhigher magnification photos (Figure 2B) around the
nerve were taken and the Iba-1+ cells in these images
were counted and reported as the ‘central flat mount’
count. There was a striking similarity in the number and
distribution of yellow spots on the fundus compared to
the Iba-1+ cells on the corresponding RPE flat mounts.
This was true for both B6-WT and rd8 mutant mice
(Figure 2C). The correlation (approaching a 1:1 ratio)
between the number of yellow spots in fundus photos
and the number of Iba-1+ cells in the flat mounts was
strong (Figure 2D, r = 0.874, P <0.0001, n = 19 eyes).
Similar to our findings on fundus yellow spots, the
central counting of Iba-1+ cells on flat mounts was sig-
nificantly higher in the rd8 mutant mice compared to
WT mice. This was the case, in young mice (young rd8 >
young WT, P <0.05) and also in old mice (old rd8 > old
WT, P <0.005) (Figure 3A).
When we counted the total number of Iba-1+ subretinal
cells, including those in the periphery, we found that rd8
mutant mice demonstrated a significant increase with age
(P <0.01, Figure 3B). In contrast, aging did not lead to an
increase in the total number of subretinal MG/MΦ in
WT mice (P = 0.9, Figure 3B). This finding was confirmed
in a subgroup analysis (3 to 6 mo, n = 9; 15 mo, n = 6;
and 18 to 19 mo, n = 7) as shown in Additional file 5:
Figure S1. Comparing the two genotypes by age (again,
counting Iba-1+ cells in the entire flat mounts), there
was no difference in the number of subretinal MG/MΦ
in young rd8/rd8 mice versus young WT mice. Yet,
there was a dramatic increase in the total number of
Iba-1+ subretinal MG/MΦ in old rd8/rd8 mice com-
pared to old WT mice (P <0.001).
The phenotype of subretinal macrophages/microglial cells
on retinal pigment epithelium flat mounts of B6-mice
changes with age and with the rd8 mutation
Next, we aimed to determine whether the subretinal MG/
MΦ expresses different markers, and whether their
phenotype changes with age or in relation to the presence
of the rd8 mutation. To this end, we stained RPE flat
mounts for Iba-1, MMR (a scavenger receptor), and/or
CD16 (a pro-inflammatory marker). Figure 4 illustrates
some of the different patterns of staining seen in our ex-
periments. We sometimes observed cells that had strong
CD16 staining (Figure 4F), while in other cases the CD16
staining was very weak (Figure 4C). It was not uncommon
to find cells that were simultaneously positive for Iba-1,
CD16 and MMR. The phenotype of subretinal MG/MΦ
of both genotypes changed with age. The proportion of
Iba-1+ MG/MΦ that were also MMR+CD16- increased
with age (Figure 4G) in both WT and rd8/rd8 mice. How-
ever, the increase was more pronounced in rd8 mutant
mice. Thus, in the old age group there was a significant
increase in MMR+CD16- cells in rd8 mutant mice
Figure 2 Central fundus spots increase with age in both B6 groups, most prominently in rd8/rd8 mice. (A) A retinal pigment epithelium
(RPE) flat mount of an old rd8 mouse stained for ionized calcium binding adaptor (Iba)-1 is shown to demonstrate the area counted as the
‘central flat mount’ (large white square). The ‘central flat mount’ is made up of four higher magnification photos (magnification 10X/1.6X optivar)
taken around the disc (smaller squares). (B) One of those higher magnification photos is shown. (C) The number of yellow spots (black bars) in
the central fundus (within a circle with a 5 disc diameter (DD) radius and centered on the disc) is very similar to the number of Iba-1+ cells (gray
bars) on the corresponding central flat mounts. There is an increase in central fundus spots in rd8/rd8 mice compared to wild-type (WT) mice in
each age group. Furthermore, there is an increase in the number of central yellow spots with age in both genotypes (young WT (n = 11), young
rd8 (n = 3); old WT (n = 11), old rd8 (n = 10)). (D) Linear regression showing a significant correlation between the number of yellow spots in central
fundus (5 DD radius) and the number of Iba-1 positive cells in the corresponding flat mount area (n = 19 eyes). Mice 2 to 8 months of age
were classified as ‘young’, while mice 14 to 20 months of age were classified as ‘old’. *P <0.05, ***P <0.001.
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CD16+ cells was increased in old rd8 mutant mice com-
pared to WT (Figure 4H, P <0.05). Interestingly, when we
looked at the central retina of old mice, there was also a
statistically significant increase in CD16+ cells in rd8 mu-
tant mice compared to WT (Figure 4I, P <0.05). A trend
towards an increase in MMR+CD16- cells in the central
retina of old rd8 mutant mice was also seen, but did not
reach statistical significance (P = 0.056).
The CD16+ subpopulation of subretinal microglia/
macrophages in both, old B6-WT mice, and particularly
rd8 mutant mice, show morphological signs of activation
Having seen that aging and the presence of the rd8 mu-
tation cause phenotypic changes in the subretinal MG/MΦ of B6 mice, we wondered if these changes were ac-
companied by morphological signs of activation [36].
We confirmed that injection of lipopolysaccharides
(LPS) intraperitoneally (i.p.) into WT mice led to a
marked increase in the accumulation of subretinal MG/
MΦ and that those cells demonstrated the typical mor-
phologic changes associated with activation, including
larger cell bodies, shorter extensions and a lower num-
ber of extensions (see Additional file 6: Figure S2). Thus,
we decided to quantitatively analyze the morphological
activation of subretinal MG/MΦ on the RPE flat mounts
of rd8 mutant and B6-WT mice, by measuring the cell
body area and the extension length using ImageJ soft-
ware. We also counted the total number of extensions
per cell and derived a single parameter, ‘microglial
Figure 3 The total number of subretinal microglia/macrophages (MG/MΦ) increases with age in C57BL/6N, but not C57BL/6J mice.
(A) Number of ionized calcium binding adaptor (Iba)-1 positive cells in the central flat mount of young and old mice showing a significant
increase in both age groups of rd8/rd8 mice compared to the age-matched wild-type (WT). (B) Number of Iba-1 positive cells in the entire/
total retinal pigment epithelium (RPE) flat mounts showing that the total number of subretinal microglia increases with age in rd8/rd8 mice,
but not in WT mice. The graphs represent the combined results of two to three experiments, which included young mice (WT, n = 10 eyes; or
rd8/rd8, n = 8 eyes), and old mice (WT, n = 13 eyes; or rd8/rd8, n = 11 eyes). Mice 2 to 8 months of age were classified as ‘young’, while mice
14 to 20 months of age were classified as ‘old’. *P <0.05, **P <0.01, ***P <0.001.
Figure 4 The phenotype of subretinal microglia/macrophages in B6-mice changes with age and with the rd8 mutation. (A-F) Representative
images of triple-stain immunohistochemistry (IHC) show staining with ionized calcium binding adaptor (Iba)-1 (A and D), Macrophage mannose
receptor (MMR) (B and E), and FcγIII/II Receptor (CD16/CD32, abbreviated as CD16) (C and F) of subretinal microglia/macrophages (MG/MΦ) on
retinal pigment epithelium (RPE)-flat mounts. Different staining patterns are shown here: some Iba-1+ cells stain strongly for CD16 (D and F),
while some Iba-1+ cells show weak or no staining for CD16 (A and C). (G) Quantification of MMR + CD16- MG/MΦ in the entire RPE-flat mount
shows that in old mice, there is a significant increase in MMR + CD16- cells in rd8/rd8 mice compared to wild-type (WT) mice. (H) In the entire
flat mount, there is also a significant increase in the number of CD16+ subretinal MG/MΦ in old rd8/rd8 mice compared to old WT. (I) The central flat
mounts demonstrate a significant increase in CD16+ MG/MΦ in old rd8/rd8 mice compared to old WT mice. There is also a trend towards an increase
in the number of MMR + CD16- cells in the central flat mounts of old rd8/rd8 mice compared to WT. For figures G-I we combined three similar
experiments using 10 young WT, 8 young rd8/rd8, 13 old WT and 10 old rd8/rd8 eyes. Mice 2 to 8 months of age were classified as ‘young’, while mice
14 to 20 months of age were classified as ‘old’. *P <0.05, ***P <0.001, #P = 0.056.
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body area)/((largest extension length) × (# of extensions)).
Subretinal MG/MΦ in B6 mice of both genotypes were di-
vided into CD16+ and CD16- subgroups and separately
analyzed using the MMAV. The CD16+ cells of old rd8
mutant mice showed a significant decrease in the number
of extensions per cell, and the extension length (Figure 5AFigure 5 (See legend on next page.)and B) when compared to both old WT and young rd8
mutant mice. There were not enough CD16+ cells in the
central young B6-WT mice to include in the analyses.
There were no differences in these measurements for
CD16- cells among the groups (data not shown). Within
each group of mice, we found that the CD16+ subpopula-
tion of Iba-1+ cells had a significantly higher MMAV
(See figure on previous page.)
Figure 5 Morphological analysis of subretinal microglia/macrophages in B6-mice. There is an increased microglia/macrophages (MG/MΦ)
activation morphology in the rd8/rd8 mice, which is accentuated in old age. (A) The average number of extensions per MG/MΦ cell is decreased
in old rd8/rd8 mice compared to both old wild-type (WT) mice and young rd8/rd8 mice. (B) The average length of the MG/MΦ cell extensions
(measured using imageJ, http://imageJ.nih.gov/ij/index.html, and expressed as standard arbitrary units) of old rd8/rd8 mice is decreased relative
to both old WT mice and young rd8/rd8 mice. (C) Quantification of MG/MΦ activation using the new parameter, microglial morphology activation
value (MMAV) is shown. MMAV combines several morphological changes known to be associated with MG/MΦ activation into a single value, and is
defined as the area of the MG/MΦ cell body divided by the product of the number of extensions and the average extension length. MMAV is
increased in FcγIII/II Receptor (CD16/CD32, abbreviated as CD16) positive cells, particularly in old rd8 mutant mice. (D). The ratio of MMAV for
CD16+ to MMAV for CD16- cells is markedly increased in both young and old rd8 mutant mice compared to old WT mice. Two similar experiments
were combined (see methods; n = 3 to 5 eyes per group, and 3 to 5 photographic fields per eye, containing 3 to 5 cells with intact cell body per field,
which were randomly selected by a masked investigator). Examples of the ionized calcium binding adaptor (Iba)-1 (E,F,I,J) and CD16 (G,H,K,L) staining
of MG/MΦ in two C57BL/6J (E,G,I,K) versus two C57BL/6N mice (F,H,J,L) are shown. Mice 2 to 8 months of age were classified as ‘young’, while mice
14 to 20 months of age were classified as ‘old’. *P <0.05, **P <0.01, ***P <0.001, #P = 0.051.
Figure 6 Subretinal microglia/macrophages (MG/MΦ) in C57BL/
6N mice express markers of activation. After processing eyes
using the freeze-substitution technique (see Methods, n = 8 eyes per
group), retina sections from C57BL/6N (A-D and F-I) or from C57BL/6J
(E and J) eyes were obtained and stained. Each section was double-
labeled with ionized calcium binding adaptor (Iba)-1 (red channel; G-J)
and one microglia/macrophage activation marker (green channel; B-E).
A control sample is also shown (secondary antibodies without primary
antibodies; A and F), which is a consecutive section of the one stained
with Iba-1 and FcγIII/II Receptor (CD16/CD32, abbreviated as CD16)
(B and G). Note the expression of CD16 and activation markers
MHC-II and iNOS in subretinal MG/MΦ in rd8 mutant samples (arrows
in B,C,D). There is no staining for MHC-II in the wild-type (WT)
subretinal MG/MΦ (E versus C).
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Furthermore, the magnitude and significance of the differ-
ence increased with age, and with the presence of the rd8
mutation (Figure 5C). When the difference in the activa-
tion morphology of CD16+ versus CD16- cells for each
group of mice was quantified, by calculating the ratio
(MMAV for CD16+)/(MMAV for CD16-), it was three
times higher in old rd8 mutant mice compared to old WT
mice (P <1 × 10−8, Figure 5D). Examples of the Iba-1 and
CD16 staining of MG/MΦ cells in two C57BL/6J mice
(Figure 5E,G,I,K) versus two C57BL/6N mice (Figure 5F,
H,J,L) are shown.
Subretinal microglia/macrophages in C57BL/6N mice
demonstrate other signs of activation
In order to corroborate that the subretinal MG/MΦ in
rd8/rd8 C57BL/6N mice express markers of activation, we
obtained retina sections using a freeze-substitution tech-
nique and performed IHC for Iba-1 in combination with
CD16, MHC-II or iNOS. We confirmed that Iba-1+ MG/
MΦ localize to the interface between RPE and photore-
ceptors and that some of them express CD16 (Figure 6B).
More importantly, we found that Iba-1+ subretinal cells
demonstrated expression of MHC-II and iNOS in C57BL/
6N (Figure 6 C,D) but not in WT eyes (Figure 6E).
Finally, EM of retinal sections in old rd8/rd8 mice re-
vealed the presence of cells between the RPE and the
photoreceptor outer segments (Figure 7A,B). The cyto-
plasm of these cells was full of ingested whorls of photo-
receptor debris (labeled with ^), lipofuscin granules (*),
multiple phagosomes with partially degraded debris (#),
and occasional melanosomes. These are findings consist-
ent with actively phagocytic MG/MΦ (Figure 7A-D).
Inflammatory and oxidative stress genes are differentially
expressed in the retinal pigment epithelium and retina of
rd8 mutant mice compared to wild-type mice
Analysis of gene expression by RT-qPCR showed the dif-
ferential expression of several genes related to oxidative
stress, complement activation, inflammation, and MG/MΦ chemoattraction, in the RPE and retina of rd8/rd8
mice compared to wt/wt mice (Figure 8). In the RNA
isolates from the RPE/subretinal MG/MΦ of rd8 mu-
tant mice the following six genes were upregulated
compared to the B6-WT controls (Figure 8A): Ccl2
(5.5-fold, P <0.05), CFB (3.3-fold, P <0.005), C3 (2.4-fold,
P <0.05), NF-kβ (1.9-fold, P <0.05), CD200R (2.7-fold,
P <0.005) and TNF-alpha (2.2-fold, P = 0.058). We sus-
pected that these pro-inflammatory genes were increased
due to oxidative stress and complement activation in the
retina of rd8 mutant mice. This hypothesis was supported
by our findings of increased expression of oxidative stress,
complement activation and inflammation related genes in
the retina of rd8 mutant mice (Figure 8B): HO-1 (1.4-fold,
Figure 7 Electron microscopy of retinal sections in old rd8/rd8
mice. Cells consistent with microglia/macrophages (MG/MΦ) were
seen between the retinal pigment epithelium (RPE) and the
photoreceptor outer segments (A,B). Higher magnification images
from these cells (C,D) demonstrate the presence of photoreceptor
outer segment debris (labeled with ^), occasional melanosomes,
lipofuscin granules (*), and multiple phagosomes with partially
degraded debris (#). The photoreceptor outer segments seen over
the microglia in A and B are labeled as ROS (rod outer segments).
Figure 8 RT-qPCR analysis of RNA from retinal pigment
epithelium (RPE)/subretinal microglia/macrophages (MG/MΦ)
isolates and from retina isolates. There is an upregulation of genes
related to oxidative stress, complement activation and inflammation in
rd8 mutant mice compared to wild-type (WT). (A) Fold changes in the
expression of target genes, in RNA isolated from RPE/subretinal MG/
MΦ from rd8 mutant mice, normalized to B6-WT. The bars represent
the average of two experiments in age-matched 6- to 8-month-old
mice, including a total of 10 rd8/rd8 and 10 WT eyes, except for
CFB (6 rd8/rd8 and 6 WT eyes). (B) Fold changes in the expression
of target genes in RNA isolated from the retina of rd8 mutant mice
normalized to B6-WT. The bars represent the average of two experiments
including a total of 11 rd8/rd8 and 11 B6 eyes. *P <0.05, **P <0.01,
***P <0.001, #P = 0.058.
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and Nrf-2 (3.2-fold, P <0.05).
Discussion
The geographic distribution of subretinal microglia/
macrophages changes with age in both C57BL/6N and
C57BL/6J mice, but the total number of microglia only
increases in C57BL6/N mice
In this work, we describe the clinical appearance and
natural history of subretinal MG/MΦ in naïve C57BL/6
mice with (C57BL/6N or ‘rd8 mutant’), or without
(C57BL/6J or WT) the rd8 mutation of the Crb1 gene.
The strong correlation between yellow fundus spots and
subretinal Iba-1+ cells suggests that most of the yellow
drusen-like fundus spots we observed are in fact subret-
inal MG/MΦ. This is in line with observations by several
groups [13,19,37]. Of course, this does not rule out the
possibility that a relatively small number of these spots
could represent intra-retinal lesions in the rd8 mutant
mice, as some groups have suggested [25,38]. We also
found that in C57BL/6J mice (in the absence of the rd8
mutation), the total number of subretinal MG/MΦ ap-
pears to remain stable with age. On the other hand, we
observed that aging does lead to an increase in the totalnumber of subretinal MG/MΦ in C57BL/6N mice. A
large portion of the subretinal MG/MΦ in young mice
are located in the far retinal periphery and may be
missed by regular fundus photos or common methods of
flat mount preparation.
Our data shows that as mice age, the distribution of
the yellow fundus spots (and the corresponding Iba-1+
cells) changes: they seem to localize further away from
the ora serrata and more towards the central retina.
These changes developed earlier and more prominently
in the rd8 mutant mice. In the rd8 mutant mice, there
was also some predilection for the inferonasal quadrant,
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fundus. We have not determined if the ‘centripetal’
change in distribution of fundus spots is due to migra-
tion of cells within the subretinal space, or if the more
posterior cells are originating from subsequent waves of
microglial migration from the inner retina and into the
subretinal space in a different area of the fundus. Experi-
ments by two groups [12,39] showed that subretinal
microglia completely turned over in 2 to 6 months. As-
suming that their observations apply to naïve mice, the
distribution of subretinal microglia at any given time
may be determined by chemoattractants secreted by
RPE cells in response to factors related to aging or ret-
inal pathology (such as the retinal degeneration associ-
ated to the rd8 mutation).
With aging, an increasing proportion of subretinal
microglia/macrophages in the C57BL/6N (rd8 mutant)
mice demonstrate a pro-inflamatory phenotype and
activated morphology compared to C57BL/6J
In studying phenotype, we used CD16 as a marker for
pro-inflammatory MG/MΦ [40-42]. CD16+ cells have
been shown to have a higher expression of proinflamma-
tory cytokines and higher potency in antigen presentation
[43]. It has been used as a marker of activated MG/MΦ
both in humans [40,43-45] and in mice [41,42,45-51].
We used MMR (CD206 or MRC-1) as a marker for a
scavenging phenotype [52,53]. MMR may have a role in
promoting clearance and reduced immunogenicity of
glycoproteins [54]. Some groups have also used CD16
as a marker of M1 macrophage phenotype [40-42], and
MMR as a marker of M2 phenotype [41,42,54]. Yet,
macrophages do not always conform to a M1 versus
M2 classification [55,56]. In fact, in our studies we ob-
served that it is not uncommon for MG/MΦ to express
both MMR and CD16 simultaneously.
As the WT mice aged, they had an increase in MMR +
CD16- cells, while CD16+ cells remained stable or slightly
decreased. This suggests a change towards a scavenging
phenotype. However, in the old rd8 mutant mice, both the
MMR + CD16- and the CD16+ cells were increased
relative to the WT mice. Importantly, we found robust
morphologic changes of activation in the CD16+ sub-
population of subretinal MG/MΦ, and these were most
prominent in the aging rd8 mutant mice. Old rd8 mu-
tant mice also had ultrastructural (EM) and immuno-
histochemical evidence of activated MG/MΦ between
the RPE and the photoreceptor outer segments. Subret-
inal MG/MΦ in rd8 mutant mice demonstrated expres-
sion of the activation markers iNOS and MHC-II.
These findings are interesting in view of recent observa-
tions by Murinello et al. [46] showing an increase in
CD16 expression (accompanied by increased MHC-II ex-
pression) in retinal MG/MΦ in an acute inflammatorymodel, and increased expression of FcγRII (one of the an-
tigens recognized by our CD16/CD32 antibody) in MG/
MΦ of early and late AMD retinal and choroidal
specimens.
Some studies suggest that MG/MΦ play a protective
role in AMD (by clearing pro-inflammatory debris)
[11,57-59], while others suggest that they promote dis-
ease progression (perhaps by secreting pro-inflammatory
or pro-angiogenic factors) [59-61]. This dichotomy has
also been described by others in the setting of uveal mel-
anoma [62], and Alzheimer’s disease [2,3]. It is thought
that as mice age, there is an increase in subretinal debris
and basal laminar deposits, even in naïve mice [63,64].
We propose that in normal aging and in the absence of
retinal pathology (as in B6 mice that do not have the rd8
mutation), the MG/MΦ are accumulating posteriorly
and changing towards a more defined scavenger pheno-
type in order to help handle this accumulation of debris.
The fact that autofluorescent lipofuscin accumulates in
subretinal MG/MΦ with age [65] suggests that one of
their roles is to clear waste products from the normal
turnover of photoreceptors. As Wong’s group and others
have suggested [36], this may involve a form of activa-
tion. However, our data suggest that this normal activa-
tion is quantitatively (low MMAV), and qualitatively
(MMR + CD16-) different from the activation seen in the
diseased retina of rd8 mutant mice. When aging is ac-
companied by retinal pathology (as in the rd8 mutant
mice), among the subretinal MG/MΦ there is an in-
creased number of cells characterized by a more pro-
inflammatory (CD16+) phenotype. Finally, our finding of
markedly different MMAVs for CD16+ MG/MΦ in rd8
mutant versus WT mice suggests that MG/MΦ activa-
tion in the subretinal space is a gradated process, not an
all-or-none phenomenon.
Oxidative stress, complement activation, and
inflammation related genes are upregulated in the rd8
mutant mice
We found that in the rd8 mutant mice, retinal pathology
is accompanied by an up-regulation of genes related to
oxidative stress (HO-1 and Nrf-2), and complement acti-
vation (C1q and C4) in retina extracts compared to WT
mice. Interestingly, a recent study [46] demonstrated de-
position of C1q in early AMD specimens. Simultan-
eously, or perhaps as a consequence, the RPE of rd8
mutant mice demonstrates an upregulation of a gene in-
volved in the chemoattraction of MG/MΦ (Ccl-2). The
RPE/MG/MΦ cells in the rd8 mutant mice also have an
increased expression of genes related to complement acti-
vation (C3 and CFB), and genes related to inflammation
(TNFα, NF-kβ and CD200R). Our findings in rd8 mutant
mice of a pro-inflammatory RPE gene expression profile
in association with increased MG/MΦ cell activation
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sults by Luo et al. [66]. They showed a markedly increased
expression of inflammatory cytokines (iNOS and Ccl2),
and complement genes (C3 and CFB) by RPE cells that
had been cultured with supernatants of activated macro-
phages. Also, Ma et al. [67] recently found an increase in
C3 and CFB in MG/MΦ isolated ex-vivo from the retinas
of old C57BL/6J mice (compared to young mice). They
propose that aging leads to an increase in complement ac-
tivation in the retina of wild-type mice. Our findings sug-
gest that this increase is even more pronounced (and
occurs at a younger age) in mice expressing the rd8 muta-
tion. The combination of all of these observations suggests
a cross-talk between retina, RPE cells and subretinal
MG/MΦ: retinal pathology leading to oxidative stress
(like the rd8 mutation in the setting of still unidentified
permissive genes) will lead to complement activation,
and activation of RPE cells, which secrete chemoattrac-
tants for MG/MΦ. The ensuing accumulation of acti-
vated subretinal MG/MΦ may further induce the
secretion of pro-inflammatory molecules by the RPE,
promoting a vicious cycle.
It should be noted, however, that among the markers
of oxidative stress and inflammation that we detected,
several molecules have actually been proposed to have a
role in controlling oxidative stress and inflammation.
Nrf-2 is usually upregulated in response to oxidative
stress; but it is in fact in charge of activating the primary
cellular defense mechanism against the cytotoxic effects
of oxidative stress. Handa’s group has recently shown
that Nrf-2 modulates smoke-induced complement acti-
vation in the RPE [68]. Also, CD200R is a receptor
expressed on MG/MΦ, which may be involved in indu-
cing regulation or quiescence of MG/MΦ [69]. Thus,
even in a distressed retina that is causing upregulation
of inflammatory mediators, there are mechanisms in
place to promote a new steady state that avoids excessive
inflammation.
Permissive/modulatory genes may be needed in addition
to the rd8 mutation for full expression of the phenotype
seen in C57BL/6N mice
It is important to emphasize that the ocular phenotype
induced by the rd8 mutation of the Crb1 gene appears
to be modulated by other genes. For example, Luhmann
et al. [24] showed that the absence of Cx3cr1 gene ex-
pression increased the phenotypic changes seen in rd8
mutant mice. The same group has recently identified a
region in chromosome 15 that may contain such modu-
latory gene(s) [25]. Furthermore, Mehalow et al. [22]
showed that rd8/rd8 mutant mice had a wide range of
phenotypic changes depending on the genetic back-
ground. In fact, it was possible to obtain rd8/rd8 mice in
which the only phenotypic expression found was adisruption of the external limiting membrane of the retina
(no significant increase in fundus spots, and no retinal
folds or pseudorosettes in retinal histological sections)
[22]. Our observations lead us to speculate that different
chemoattractant/inflammatory mediator milieus can lead
to accumulation of MG/MΦ that may vary in their level
and type of activation, and the expression of regulatory
genes. In other words, it is possible that genes that regu-
late MG/MΦ chemotaxis and activation may be part of
the still unidentified modulatory genes involved in regulat-
ing the phenotypic expression of the rd8 mutation. There
is an acute need for further work directed at identifying
these modulatory genes.
Conclusions
Our results demonstrate that C57BL/6N (Crb1rd8/rd8)
mice have increased accumulation of subretinal MG/MΦ
displaying phenotypical (CD16+), morphological, and
gene-expression characteristics consistent with a pro-
inflammatory shift. This is in contrast to a more scaven-
ging, and less activated MG/MΦ phenotype in C57BL/6J
mice. These findings are likely triggered by a ‘diseased ret-
inal state’ caused by the combination of the rd8 mutation
and yet unidentified permissive/modulatory genes in the
C57BL/6N mice. We suspect that in the pathological set-
tings of AMD, retinal dystrophies and human diseases in-
volving different CRB1 mutations (for example, Lebers
congenital amaurosis, and childhood-onset dystrophies),
the level of activation of subretinal MG/MΦ increases sig-
nificantly. Further studies are needed to better understand
MG/MΦ migration, activation and differentiation under
physiologic versus pathologic conditions, with the goal of
finding ways to manipulate these processes for therapeutic
purposes.
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Additional file 1: Table S1. List of antibodies and dilutions used for
retinal pigment epithelium (RPE)-flatmount immunohistochemistry.
Additional file 2: Table S2. List of antibodies and dilutions used for
immunostaining of microglia/macrophages in mouse retina sections.
Additional file 3: Table S3. Primers used for qPCR analysis of gene
expression by RPE/microglia/macrophages RNA isolates.
Additional file 4: Table S4. Primers used for qPCR analysis of gene
expression by retina RNA isolates.
Additional file 5: Figure S1. Subgroup analysis of C57BL/6J (wild-type,
WT) eyes, looking at three narrow age groups, confirmed that there was
no difference in the total number of subretinal ionized calcium binding
adaptor (lba)-1 microglia/macrophages as WT mice aged. (n.s., no statistically
significant difference).
Additional file 6: Figure S2. Intraperitoneal lipopolysaccharides leads
to activated subretinal microglia/macrophages. Eyes were enucleated from
old B6-wild-type (WT) mice, either naive (top panels) or 16 h after
intraperitoneal (i.p.) injection of 100 μl lipopolysaccharides (LPS) (bottom
panels; lipopolysaccharide was from salmonella enteric serotype
typhimurium, 1mg/ml, Sigma-Aldrich, Inc., St. Louis, MO, USA; Cat. No.
L6143). Retinal pigment epithelium (RPE) flat mounts were prepared
Aredo et al. Journal of Neuroinflammation  (2015) 12:6 Page 13 of 14and stained for ionized calcium binding adaptor (lba)-1 (left panels) or
Fcγ III/II receptor (CD16/CD32, abbreviated as CD16, right panels). LPS eyes
had a dramatic increase in the number of subretinal microglia/macrophages
(MG/MΦ) (bottom panels versus top panels). The LPS-activated MG/MΦ had
large cell bodies and few extensions. Furthermore, while only a few MG/MΦ
were strongly positive for CD16 in the naive mice (right top panel), many
were strongly positive for CD16 in the LPS-activated mice (right bottom
panel). Scale bar in top left panel.
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